Clover Biopharmaceuticals Ltd banner
C

Clover Biopharmaceuticals Ltd
HKEX:2197

Watchlist Manager
Clover Biopharmaceuticals Ltd
HKEX:2197
Watchlist
Price: 1.91 HKD -8.61% Market Closed
Market Cap: HK$2.5B

Clover Biopharmaceuticals Ltd
Investor Relations

Clover Biopharmaceuticals Ltd. engages in the research and development of biopharmaceutical products. The company is headquartered in Chengdu, Sichuan and currently employs 814 full-time employees. The company went IPO on 2021-11-05. The firm's main business is the development of new vaccines and biotherapeutic candidates for infectious diseases, cancer and autoimmune diseases. The firm's products are mainly used to treat the new coronavirus, malignant ascites, and ankylosing spondylitis.

Show more
Loading
2197
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Peng Liang Ph.D.
Founder, Chief Scientific Officer & Chairman of the Board
No Bio Available
Mr. Joshua G. Liang
CEO & Executive Director
No Bio Available
Dr. Yang Li Ph.D.
Chief Technology Officer
No Bio Available
Ms. Htay Htay Han MBBS
Chief Medical Officer of Vaccine
No Bio Available
Dr. Berry Michael Ph.D.
Chief Technical Operation Officer
No Bio Available
Ms. Abigail Bracha Ph.D.
Senior Vice President of Corporate Strategy & Business Development
No Bio Available
Ms. Tracy Wang
Senior Vice President of Head of Regulatory Affairs, China
No Bio Available
Dr. Nicholas Jackson M.Sc., Ph.D.
President of Global Research & Development
No Bio Available
Mr. LiongHo Chua
President of Greater China
No Bio Available
Dr. Igor Smolenov M.D., Ph.D.
Executive Vice President of Global Clinical Development Vaccines
No Bio Available

Contacts

Address
SICHUAN
Chengdu
B5-19, Building 1, High-tech Incubation Park, No. 1480 North Section of Tianfu Avenue, Chengdu High-tech Zone, China (Sichuan) Pilot Free Trade Zone
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett